PPD Opens Vaccine Study Center In China
[Star-News, Wilmington, N.C.]
From Star-News (Wilmington, NC) (April 27, 2010)
Apr. 27--PPD Inc. has opened a vaccine clinical research center in Taizhou, China.
The Wilmington-based contract research organization said the center will provide clinical monitoring services to global and local biopharmaceutical companies seeking to develop vaccines in China.
Located at the Taizhou China Medical City, the center will help biopharmaceutical companies address requirements for conducting vaccine clinical trials in the country.
Vaccine studies in China are conducted by the Chinese Center for Disease Control and Prevention instead of at clinics or by investigators at hospitals, and they require thousands of patients for enrollment, compared to hundreds for studies conducted in other countries. "The vaccines market is one of the fastest growing segments in the industry, and in China the clinical trial market is growing at about 20 percent each year," Simon Britton, PPD’s vice president of clinical development for Asia Pacific, said in a statement.
The China Medical City has become a national hub for international and domestic pharmaceutical, biomedical and biotechnology companies and is part of a long-term plan to advance Taizhou as a global leader in research and development.
PPD opened its first office in China in 2003 and is now the largest contract research organization in the country with nearly 1,100 employees, the company said. Its acquisitions of Excel PharmaStudies Inc. and BioDuro LLC, last year strengthened the company’s drug discovery and development services in China.
On Monday, PPD also announced that Takeda Pharmaceutical Co.’s new drug application for NESINA (alogliptin) -- a treatment for type 2 diabetes -- has been approved by the Japanese Ministry of Health, Labor and Welfare.
PPD’s compound partnering division collaborated with Takeda to develop this product.
Under PPD’s agreement with Takeda, PPD is entitled to a $7.5 million milestone payment from Takeda.
Wayne Faulkner: 343-2329
On Twitter.com: @bizniznews
To see more of The Star-News or to subscribe to the newspaper, go to http://www.starnewsonline.com.
Copyright (c) 2010, Star-News, Wilmington, N.C.
Distributed by McClatchy-Tribune Information Services.
For reprints, email email@example.com, call 800-374-7985 or 847-635-6550, send a fax to 847-635-6968, or write to The Permissions Group Inc., 1247 Milwaukee Ave., Suite 303, Glenview, IL 60025, USA.
Posted: April 2010
Recommended for you